AltMountain

EG Oncopep, LLC

Organized in Delaware, United States · Advised by EG Capital · Private fund ID 805-8630402643
Private equity fund

EG Oncopep, LLC is a private equity fund organized in Delaware, United States and advised by EG Capital. Its adviser reported $2,400,000 in gross assets for the fund on Form ADV, filed Mar 26, 2024. It reported 19 beneficial owners. The minimum investment it accepts is $50,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors.

Gross assets
$2,400,000As reported on Form ADV
Beneficial owners
19
Minimum investment
$50,000
Who can invest
Accredited investorsSection 3(c)(1): up to 100 owners
Fund type
Private equity fund
Domicile
Delaware, United States
Adviser
EG Capital · New York, NY · CRD 162850
Reported on
Mar 26, 2024Adviser's Form ADV

From SEC filings, not verified. This information is republished from the adviser's Form ADV (Schedule D, Section 7.B.(1)) in the SEC's public Form ADV data, which currently runs through filings made by Dec 26, 2024. Figures are as of the adviser's filing and may have changed since. It is not an offer, solicitation or recommendation, AltMountain has not reviewed the fund, and gross assets are not performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction

Questions about EG Oncopep, LLC

What is the minimum investment for EG Oncopep, LLC?

According to its adviser's Form ADV filed Mar 26, 2024, the minimum investment EG Oncopep, LLC accepts is $50,000.

Who can invest in EG Oncopep, LLC?

EG Oncopep, LLC is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1).

How large is EG Oncopep, LLC?

Its adviser reported $2,400,000 in gross assets on Form ADV filed Mar 26, 2024. Gross assets include borrowed money and are not the same as net assets or performance.

Who manages EG Oncopep, LLC?

EG Oncopep, LLC is advised by EG Capital, based in New York, NY.

Other funds advised by EG Capital